Mie Chuo Medical Center

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

Each strip is that field’s whole ranked pool, with the notch where Mie Chuo Medical Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 10.6× the share of its output that it takes of world research.

1. Pulmonary and Respiratory MedicineSubfield · 28.9 works11×

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Pharmacology, Toxicology and Pharmaceutics 4.3×
• Medicine 4.2×
• Immunology and Microbiology 2.0×
• Veterinary 1.5×
• Neuroscience 1.2×
• Nursing 1.0×
• Dentistry 0.8×
• Biochemistry, Genetics and Molecular Biology 0.7×
• Health Professions 0.6×
• Environmental Science 0.3×
• Physics and Astronomy 0.3×
• Psychology 0.2×
• Mathematics 0.2×
• Engineering 0.1×
• Computer Science 0.1×
• Social Sciences 0.1×
• Chemistry 0.1×
• Earth and Planetary Sciences 0.1×
• Arts and Humanities 0.1×
• Agricultural and Biological Sciences 0.0×
• Economics, Econometrics and Finance 0.0×

Ranked on the composite score, Fujimaro Ishida, Hiroyuki Yuasa and Katsutoshi Adachi lead among researchers whose main affiliation is Mie Chuo Medical Center.

1. 1 🇯🇵 Fujimaro Ishida Japan · #968,091 worldwide 23 citations · 15 works
2. 2 🇯🇵 Hiroyuki Yuasa Japan · #1,177,491 worldwide 8 citations · 25 works
3. 3 🇯🇵 Katsutoshi Adachi Japan · #1,543,039 worldwide 3 citations · 15 works

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Treatment, Surgical Management, Chemotherapy, Management, Risk Factors and Clinical Practice Guidelines.

By volume in 2022–2025: Lung Cancer Diagnosis and Treatment, Venous Thromboembolism Diagnosis and Management, Aortic Disease and Treatment Approaches and Gastrointestinal Tumor Research and Treatment.

1. 1 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 3 works
2. 2 Venous Thromboembolism Diagnosis and Management Internal Medicine 2 works
3. 3 Aortic Disease and Treatment Approaches Pulmonary and Respiratory Medicine 2 works
4. 4 Gastrointestinal Tumor Research and Treatment Gastroenterology 2 works
5. 5 Acute Ischemic Stroke Management Epidemiology 2 works
6. 6 Research studies in Vietnam Ecology 2 works
7. 7 Intracranial Aneurysms: Treatment and Complications Neurology 2 works
8. 8 Myasthenia Gravis and Thymoma Neurology 2 works
9. 9 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
10. 10 Abdominal vascular conditions and treatments Surgery 2 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 78% higher than in 2013–2017.

• Mie University
• Mie University Hospital
• Mie Prefectural College Of Nursing
• National Mie Hospital
• Tsu City College
• Mie Chukyo University
• Mie Prefectural Education Center
• Takada Junior College